C9285 HCPCS code: Lidocaine 70 mg/tetracaine 70 mg, per patch
C9285 is the HCPCS Level II code for lidocaine 70 mg/tetracaine 70 mg, per patch. Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met. The NCCI unit limit is 2 per day on outpatient hospital claims.
Code details
| Field | Value |
|---|---|
| Section | C codes — Outpatient PPS (hospital outpatient temporary codes) |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 53 |
| BETOS category | O1E — Other drugs |
| Added | 2011-07-01 |
| Last action effective | 2014-01-01 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 2 | Prescribing Information |
| practitioner claims | 2 | Prescribing Information |
What changed for C9285
- 2011-07-01: C9285 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code C9285?
C9285 is the HCPCS Level II code for lidocaine 70 mg/tetracaine 70 mg, per patch. Short descriptor: "Patch, lidocaine/tetracaine".
Does Medicare cover C9285?
Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.
How many units of C9285 can be billed per day?
2 on outpatient hospital claims; 2 on practitioner claims (NCCI medically unlikely edits).
Related C92 codes
- C9248 — Injection, clevidipine butyrate, 1 mg
- C9250 — Human plasma fibrin sealant, vapor-heated, solvent-detergent (artiss), 2 ml
- C9254 — Injection, lacosamide, 1 mg
- C9257 — Injection, bevacizumab, 0.25 mg
- C9275 — Injection, hexaminolevulinate hydrochloride, 100 mg, per study dose
- C9290 — Injection, bupivacaine liposome, 1 mg
- C9293 — Injection, glucarpidase, 10 units
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under C9285
- Watch C9285 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for C9285
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.